Volume 1,Issue 3
Discussion on the Treatment of Endometrial Polyps in Chinese Medicine Based on the Theory of “Six Depressions”
Endometrial polyps (EPs) are caused by excessive endometrial hyperplasia, and their incidence has gradually increased in recent years, becoming a common gynecological disease in clinical practice. Based on Zhu Danxi’s “Six Depressions” theory, this study aims to construct a theoretical system for TCM (Traditional Chinese Medicine) syndrome differentiation and treatment of endometrial polyps, providing new insights for clinical treatment. Through a literature research approach, this study systematically reviews the theoretical connotations of the “Six Depressions” theory and combines it with modern medical understanding of the pathological mechanisms of EPs to analyze their intrinsic connections. Consequently, a TCM syndrome differentiation and treatment system for EPs based on the “Six Depressions” theory is constructed. The study proposes that the core pathogenesis of EPs is “stagnation in the uterine cavity,” with “Qi” depression as the precursor, leading to mutual transformations among blood stasis, phlegm-dampness, fire depression, and food stagnation. A syndrome differentiation and treatment plan encompassing four main syndromes is established. Building on this foundation, the article directly addresses the core pathogenesis of “stagnation in the uterine cavity”, further elucidating the relationship between the “Six Depressions” theory and EPs. This provides a theoretical basis and diagnostic and treatment foundation for the clinical management of endometrial polyps characterized by “Qi” stagnation, internal blood stasis, internal fire depression, and phlegm-food stagnation.
[1] Wang Y, Li M, Lu M, 2019, Clinical Research Progress on Endometrial Polyps Complicated with Infertility. International Journal of Gynecology and Obstetrics, 46(2): 220–224.
[2] Zeng W, Jin P, Su S, et al., 2020, Analysis of High-Risk Factors for Recurrence and Prevention After Hysteroscopic Endometrial Polypectomy in Women of Childbearing Age. Progress in Obstetrics and Gynecology, 29(6): 453–455.
[3] Hiraoka T, Osuga Y, Hirota Y, 2023, Current Perspectives on Endometrial Receptivity: A Comprehensive Overview of Etiology and Treatment. Journal of Obstetrics and Gynaecology Research, 49(10): 2397–2409.
[4] Peng X, Li T, Xia E, et al., 2009, A Comparison of Estrogen Receptor and Progesterone Receptor Expression in Endometrial Polyps and Endometrium of Premenopausal Women. Journal of Obstetrics and Gynaecology, 29(4): 340–346.
[5] Guo M, Shi Y, 2021, Comprehensive Understanding of the Diagnosis and Differential Diagnosis of Endometrial Polyps. Chinese Journal of Family Planning & Gynecology, 13(7): 17–19.
[6] Worldwide AAGL, 2012, Practice Guidelines for the Diagnosis and Management of Endometrial Polyps. Journal of Minimally Invasive Gynecology, 19(1): 3–10.
[7] Sheng K, Lyons S, 2020, To Treat or Not to Treat? An Evidence-Based Practice Guide for the Management of Endometrial Polyps. Climacteric, 23(4): 336–342.
[8] Vitale S, Haimovich S, Lagana A, et al., 2021, Endometrial Polyps: An Evidence-Based Guide to Diagnosis and Management. European Journal of Obstetrics & Gynecology and Reproductive Biology, 260: 70–77.
[9] Banas T, Pitynski K, Mikos M, et al., 2018, Endometrial Polyps and Benign Endometrial Hyperplasia Exhibit an Increased Prevalence of DNA Fragmentation Factors 40 and 45 (DFF40 and DFF45) Along with the Antiapoptotic B-Cell Lymphoma (Bcl-2) Protein Compared to Normal Human Endometria. International Journal of Gynecological Pathology, 37(5): 431–440.
[10] Dahmoun M, Backstrom T, Boman K, et al., 2003, Apoptosis, Proliferation, and Hormone Receptors in Endometrial Carcinoma: Results Vary Depending on the Methods of Analysis. International Journal of Oncology, 22(1): 115–122.
[11] Tian W, Zhang H, Xue F, 2023, Interpretation of the Chinese Expert Consensus on the Diagnosis and Treatment of Endometrial Polyps (2022 Edition). Journal of Practical Obstetrics and Gynecology, 39(1): 29–33.
[12] Sun Y, Feng L, 2021, New Perspectives on the Surgical Treatment of Endometrial Polyps. Chinese Journal of Family Planning & Obstetrics and Gynecology, 13(7): 23–24.
[13] Guo W, Zhang S, 2020, Progress in the Treatment of Endometrial Polyps with Traditional Chinese and Western Medicine. Journal of Guangxi University of Chinese Medicine, 23(2): 64–68.
[14] Dong X, Duan Y, Gao C, 2018, Interpretation of “Yu”. China Journal of Traditional Chinese Medicine and Pharmacy, 33(2): 462–465.
[15] Huang X, Zhu A, Yu Y, et al., 2022, A Historical Review of the Origins and Development of “Yu” Syndrome. China Journal of Traditional Chinese Medicine and Pharmacy, 37(10): 5699–5703.
[16] Li Y, 2018, Investigation and Analysis of Related Factors of the Occurrence and Malignant Transformation of Endometrial Polyps and Their TCM Syndromes, thesis, Beijing University of Chinese Medicine.
[17] Wang J, Wang X, Wang P, 2019, Discussion on the Diagnostic and Therapeutic Characteristics of Zhu Danxi’s Menstrual Disorders. Clinical Journal of Traditional Chinese Medicine, 31(4): 674–678.
[18] Shi L, 2021, Clinical Study on the Prevention and Treatment of Postoperative Endometrial Polyps of Damp-Heat Stasis Type with Xiaoji Huayu Decoction, thesis, Nanjing University of Chinese Medicine.
[19] Li H, Tong X, Wu J, et al., 2007, Discussion on the Pathogenesis and Syndrome Differentiation and Treatment of Pre-Diabetes and Early-Stage Type 2 Diabetes Mellitus in Obesity. Chinese Journal of Basic Medicine in Traditional Chinese Medicine, 2007(7): 529–530.
[20] Zhao S, Lu Y, Tian Z, et al., 2020, Clinical Effect of Modified Xiaoyao Powder Combined with Escitalopram Oxalate in the Treatment of Elderly Patients with Post-Stroke Depression of Liver Depression and Fire Transformation Type. China Medical Herald, 17(20): 97–100.
[21] Miao Y, 2014, Overview of Pharmacological Research on Xiaoyao Powder. Chinese Prescription Drugs, 12(9): 141–142.
[22] Zhou H, Qu S, Mao Q, 2020, Comparative Study on the Clinical Effect of Modified Kidney-Tonifying and Blood-Activating Ovulatory Promotion Decoction and Modified Xiaoyao Powder in the Treatment of Ovulatory Dysfunction Infertility and Their Impact on Ovulation Outcomes. Journal of Liaoning University of Traditional Chinese Medicine, 22(7): 218–220.
[23] Luo X, Zhang L, Zou Z, et al., 2023, Exploration of the Ameliorative Effect of Poria Cocos on Lipopolysaccharide-Induced Acute Depressive-Like Behavior in Mice Based on Neurotransmitters and Inflammatory Factors. China Journal of Traditional Chinese Medicine and Pharmacy, 38(5): 1989–1995.
[24] Chen L, Lu S, 2020, Lu Su’s Experience in Differentiating and Treating Endometrial Polyps. Chinese Journal of Basic Medicine in Traditional Chinese Medicine, 26(7): 998–1000.
[25] Xue Q, Zhang J, Zhao Y, 2018, Clinical Observation on the Prevention of Postoperative Recurrence of Endometrial Polyps With Modified Qingjing Powder. China’s Naturopathy, 26(9): 23–25.